British Biotechnology company Mycofeast has acquired New Zealand-based precision fermentation start-up Daisy Lab. Mycofeast was founded in 2023 and is headquartered in Oxford with a biotechnology facility in California, US, and a 16m litre fermentation plant in Poland.

The company’s portfolio includes carotenoids, dairy proteins and other biologically produced ingredients and compounds, powered by its AI powered innovation engine Evolutia Bio.

Daisy Lab, based in Auckland and founded in 2021, develops proteins claimed to be bioidentical to dairy proteins through precision fermentation. One of its key focuses is lactoferrin.